PDS Biotechnology Corporation
NASDAQ:PDSB
Earnings Announcements
PDS Biotech Reports Fourth-Quarter Results
Published: 03/31/2022 12:19 GMT
PDS Biotechnology Corporation (PDSB) - Pds Biotech Provides Business Update and Reports Fourth-quarter and Full-year 2021 Financial Results.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.31
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.28
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.31
More details on our Analysts Page.